Deferoxamine Injection and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Deferoxamine Injection and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: deferoxamine
Brand name: Desferal
Synonyms: Deferoxamine
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Deferoxamine Injection-Lithium ER
- Deferoxamine Injection-Lithium Oral Solution
- Deferoxamine Injection-Lithium Salts
- Deferoxamine Injection-Lithium Syrup and Oral Solution
- Deferoxamine Injection-Lithobid
- Deferoxamine Injection-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Deferoxamine Mesylate
- Lithium Controlled-Release and Extended-Release Tablets-Defibrotide
- Lithium Controlled-Release and Extended-Release Tablets-Defibrotide Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-Defibrotide Sodium
- Lithium Controlled-Release and Extended-Release Tablets-Definity
- Lithium Controlled-Release and Extended-Release Tablets-Defitelio